Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Abel Salazar Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal
Search for other papers by Sule Canberk in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Search for other papers by Joana C. Ferreira in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal
Search for other papers by Luísa Pereira in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Search for other papers by Rui Batısta in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Search for other papers by Andre F. Vieira in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal
Search for other papers by Paula Soares in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal
Abel Salazar Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal
Department of Pathology and Oncology, Centro Hospitalar São João, Porto, Portugal
Search for other papers by Manuel Sobrinho Simões in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal
Search for other papers by Valdemar Máximo in
Google Scholar
PubMed
cancer predisposition, particularly in PTC, we analyzed the prevalence of germline/somatic variants in the largest PTC case series available in The Cancer Genome Atlas (TCGA), the most comprehensive multiplatform data portal. Materials and Methods
Search for other papers by Dorothée Bouron-Dal Soglio in
Google Scholar
PubMed
Department of Human Genetics, McGill University, Montreal, Québec, Canada
Search for other papers by Leanne de Kock in
Google Scholar
PubMed
Search for other papers by Richard Gauci in
Google Scholar
PubMed
Search for other papers by Nelly Sabbaghian in
Google Scholar
PubMed
Department of Endocrinology and Diabetes, Princess Margaret Hospital for Children, Subiaco, Washington, Australia
Search for other papers by Elizabeth Thomas in
Google Scholar
PubMed
Search for other papers by Helen C. Atkinson in
Google Scholar
PubMed
King Edward Memorial Hospital, Perth, Washington, Australia
Search for other papers by Nicholas Pachter in
Google Scholar
PubMed
Search for other papers by Simon Ryan in
Google Scholar
PubMed
Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Washington, Australia
Search for other papers by John P. Walsh in
Google Scholar
PubMed
Search for other papers by M. Priyanthi Kumarasinghe in
Google Scholar
PubMed
Search for other papers by Karen Carpenter in
Google Scholar
PubMed
Search for other papers by Ayça Aydoğan in
Google Scholar
PubMed
Search for other papers by Colin J.R. Stewart in
Google Scholar
PubMed
Department of Human Genetics, McGill University, Montreal, Québec, Canada
Department of Medical Genetics,
Search for other papers by William D. Foulkes in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, School
Search for other papers by Catherine S. Choong in
Google Scholar
PubMed
diagnosed with benign or malignant disease. In these situations, the phenotypic presentation of a patient and relatives must be taken into account to determine the most appropriate genetic test. Patients who harbour a germ-line mutation associated with a
Search for other papers by Marek Niedziela in
Google Scholar
PubMed
Search for other papers by Nelly Sabbaghian in
Google Scholar
PubMed
Department of Human Genetics, McGill University, Montreal, Québec, Canada
Search for other papers by Leanne de Kock in
Google Scholar
PubMed
Department of Human Genetics, McGill University, Montreal, Québec, Canada
Search for other papers by William D. Foulkes in
Google Scholar
PubMed
was followed by chemotherapy. In view of the PPB diagnosis, genetic analysis was performed, which identified a germline DICER1 pathogenic variant (c.2062C>T, p.R688*)in the child. The father and paternal aunt (each of whom had MNG), the younger
Inserm U1173, Université Versailles-Saint-Quentin, Montigny-Le-Bretonneux, France
Search for other papers by Laure Cazabat in
Google Scholar
PubMed
Search for other papers by Aglae Terray in
Google Scholar
PubMed
Search for other papers by Philippe de Mazancourt in
Google Scholar
PubMed
Search for other papers by Jacques Ropers in
Google Scholar
PubMed
UMR 8104, Institut Cochin, Paris, France
Search for other papers by Lionel Groussin in
Google Scholar
PubMed
Inserm U1173, Université Versailles-Saint-Quentin, Montigny-Le-Bretonneux, France
Search for other papers by Marie-Laure Raffin-Sanson in
Google Scholar
PubMed
thyroid cancer risk in Hispanics. Endocr Connect 2016; 5: 123–127. 10.1530/EC-16-0017 27097599 7 Weeks AL, Wilson SG, Ward L, Goldblatt J, Hui J, Walsh JP: HABP2 germline variants are uncommon in familial nonmedullary thyroid cancer. BMC Med Genet
Search for other papers by Thomas Karrasch in
Google Scholar
PubMed
Search for other papers by Saskia M. Herbst in
Google Scholar
PubMed
Search for other papers by Ute Hehr in
Google Scholar
PubMed
Search for other papers by Andreas Schmid in
Google Scholar
PubMed
Search for other papers by Andreas Schäffler in
Google Scholar
PubMed
variant p.Tyr826Ser in exon 14 is unclear and no scientific publications on this genotype have been published so far. What Does This Case Report Add? • In the absence of functional studies, the plausibility of pathologic significance of a detected
Search for other papers by Ségolène Hescot in
Google Scholar
PubMed
Search for other papers by Julien Masliah-Planchon in
Google Scholar
PubMed
Search for other papers by Pauline du Rusquec in
Google Scholar
PubMed
Search for other papers by Célia Dupain in
Google Scholar
PubMed
Search for other papers by Maud Kamal in
Google Scholar
PubMed
Search for other papers by Vincent Servois in
Google Scholar
PubMed
Search for other papers by Ivan Bieche in
Google Scholar
PubMed
status was stable and the TMB was low with 6.3 variants/Mb. Because of the allele frequency of the missense variant which was not tested in the initial germline mutation, we performed an NGS on patient DNA that confirmed a germline mutation. The disease
Search for other papers by Elen Dias Accordi in
Google Scholar
PubMed
Search for other papers by Paraskevi Xekouki in
Google Scholar
PubMed
Search for other papers by Bruna Azevedo in
Google Scholar
PubMed
Search for other papers by Rodrigo Bertollo de Alexandre in
Google Scholar
PubMed
Álvaro Center for Analysis and Clinical Research - Diagnósticos da América (DASA), Cascavel, Brazil
Search for other papers by Carla Frasson in
Google Scholar
PubMed
Search for other papers by Siliane Marie Gantzel in
Google Scholar
PubMed
Search for other papers by Georgios Z. Papadakis in
Google Scholar
PubMed
Search for other papers by Anna Angelousi in
Google Scholar
PubMed
Search for other papers by Constantine A. Stratakis in
Google Scholar
PubMed
Search for other papers by Vanessa Santos Sotomaior in
Google Scholar
PubMed
Section on Endocrinology and Genetics, Program on Developmental Endocrinology and Genetics (PDEGEN) and Pediatric Endocrinology Inter-Institute Training Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH)
Search for other papers by Fabio R. Faucz in
Google Scholar
PubMed
shown). Discussion SDHx variants can be associated with PTC [ 13 ]. In addition, approximately 12% of the wild-type GIST without personal or family history of paraganglioma have germline mutations in SDHB or SDHC [ 32 ]. We described a
Search for other papers by Minoru Kihara in
Google Scholar
PubMed
Search for other papers by Akira Miyauchi in
Google Scholar
PubMed
Search for other papers by Hiroshi Yoshida in
Google Scholar
PubMed
Search for other papers by Osamu Yamada in
Google Scholar
PubMed
Search for other papers by Hiroo Masuoka in
Google Scholar
PubMed
Search for other papers by Tomonori Yabuta in
Google Scholar
PubMed
Search for other papers by Takuya Higashiyama in
Google Scholar
PubMed
Search for other papers by Mitsuhiro Fukushima in
Google Scholar
PubMed
Search for other papers by Yasuhiro Ito in
Google Scholar
PubMed
Search for other papers by Kaoru Kobayashi in
Google Scholar
PubMed
Search for other papers by Akihiro Miya in
Google Scholar
PubMed
sporadic or hereditary variant [ 1 ]. Hereditary MTC arises as a component of multiple endocrine neoplasia (MEN) type 2A or 2B or as familial MTC (FMTC). These are genetic tumor syndromes caused by germline mutations in the RET proto-oncogene and are
Search for other papers by Markus Eszlinger in
Google Scholar
PubMed
Search for other papers by Alexandra Stephenson in
Google Scholar
PubMed
Search for other papers by Shideh Mirhadi in
Google Scholar
PubMed
Search for other papers by Konrad Patyra in
Google Scholar
PubMed
Search for other papers by Michael F Moran in
Google Scholar
PubMed
Search for other papers by Moosa Khalil in
Google Scholar
PubMed
Department of Pediatrics, Turku University Hospital, Turku, Finland
Search for other papers by Jukka Kero in
Google Scholar
PubMed
Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada
Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Department of Medicine, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
Introduction Nonautoimmune hyperthyroidism (NAH) is caused by a constitutively activating thyroid stimulating hormone receptor (TSHR) germline mutation. Germline mutations in TSHR lead to sporadic and familial NAH (SNAH, FNAH) whereas somatic
Search for other papers by Julia A Baran in
Google Scholar
PubMed
Search for other papers by Mya Bojarsky in
Google Scholar
PubMed
Search for other papers by Stephen Halada in
Google Scholar
PubMed
Search for other papers by Julio C Ricarte-Filho in
Google Scholar
PubMed
Search for other papers by Amber Isaza in
Google Scholar
PubMed
Search for other papers by Aime T Franco in
Google Scholar
PubMed
Search for other papers by Lea F Surrey in
Google Scholar
PubMed
Search for other papers by Tricia Bhatti in
Google Scholar
PubMed
Search for other papers by Zubair Baloch in
Google Scholar
PubMed
Search for other papers by N Scott Adzick in
Google Scholar
PubMed
Division of Oncology, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
Search for other papers by Sogol Mostoufi-Moab in
Google Scholar
PubMed
Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Search for other papers by Ken Kazahaya in
Google Scholar
PubMed
Search for other papers by Andrew J Bauer in
Google Scholar
PubMed
variant) ( 17 , 18 , 28 , 29 , 30 ). Patients with germline mutations in thyroid cancer predisposition syndromes, such as PTEN Hamartoma Tumor Syndrome and DICER1 syndrome, were excluded from the analysis. Preoperative features, clinicopathologic